-
Working on stability data on 2 to 8 C, temp range for Sputnik V vaccine: Dr Reddy’s
expresspharma
April 16, 2021
He said necessary cold storage infrastructure is in place to distribute the Sputnik V vaccine in India, which would be available during this quarter.
-
Google commits funds for 250k vaccinations in LMIC
expresspharma
April 16, 2021
Google pledged funds for 250,000 COVID-19 vaccinations and technical assistance towards vaccine delivery in low- and middle-income countries amidst a surge in infections across the world.
-
UK trial evaluating ‘mix and match’ COVID-19 vaccine regimens expanded
pharmatimes
April 15, 2021
A UK trial evaluating the safety of mixing different COVID-19 vaccines is set to be expanded to include Moderna and Novavax’s respective jabs.
-
Supply scarcity is delaying full scale production of COVID-19 vaccine: Novavax
expresspharma
April 15, 2021
Novavax has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages including bags used to grow cells, a company spokeswoman told Reuters.
-
European Commission to not renew AstraZeneca and J&J vaccine contracts at expiry: Reports
expresspharma
April 15, 2021
The European Commission is seeking clarification from J&J about the company’s “completely unexpected” announcement of delays in COVID-19 vaccine deliveries to the EU.
-
Aon Launches Innovative Industry Collaboration to Protect Global COVID-19 Vaccine Shipments
prnasia
April 14, 2021
Aon plc , a leading global professional services firm providing a broad range of risk, retirement and health solutions, introduced a new solution, through broad industry collaboration, that will provide supply chain protection for global COVID-19 ...
-
US halts J&J COVID-19 vaccine after six women under 50 develop rare blood clots
expresspharma
April 14, 2021
US federal health agencies recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six women under 50 given the shot developed rare blood clots, dealing a fresh setback to efforts to tackle the pandemic.
-
EMA initiates review of J&J’s Covid-19 vaccine over blood clot reports
pharmaceutical-technology
April 13, 2021
The European Medicines Agency (EMA) has initiated review of Johnson & Johnson’s (J&J) single-shot Covid-19 vaccine over reports of rare blood clots in four individuals in the US.
-
China mulls combining COVID-19 vaccines to enhance protection rate
expresspharma
April 13, 2021
Available data shows Chinese vaccines lag behind others including Pfizer and Moderna in terms of efficacy, but require less stringent temperature controls during storage.
-
SEC of CDSCO recommends approval to Sputnik V for EUA in India
expresspharma
April 13, 2021
The DCGI will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India.